Early partner sites
LifeSavr
For Local Authorities, Housing and Harm Reduction Teams
LifeSavr is a chest-based wearable being developed to enable detection and management of both clinical and recreational opioid overdoses.
We are currently in the product development phase, with plans to launch in 2026.
If you are interested in learning more or collaborating, please do not hesitate to reach out through our “Speak to the Team” section.
LifeSavr is in development. It is not approved for clinical or commercial use.
- ✔Chest-worn device — designed for accuracy
 - ✔Detects risk and alerts pre-determined responders
 - ✔Built for people who use drugs
 
We are currently speaking with
Local authorities, housing teams, harm reduction services and health boards who support people at high risk of overdose.
LifeSavr is a prototype. It is not CE- or UKCA-marked and is not approved for clinical or commercial use.
Organisations Involved in Research & Development
NHS ScotlandChief Scientist Office (Scottish Government)University of SouthamptonHealth Innovation South East Scotland (HISES)Office for Life SciencesUniversity of Edinburgh
Listing reflects funding, collaboration, or engagement and does not imply endorsement.